Literature DB >> 19076843

Comparison of the new InoDiag automated fluorescence multiplexed antigen microarray to the reference technique in the serodiagnosis of atypical bacterial pneumonia.

F Gouriet1, P-Y Levy, L Samson, M Drancourt, D Raoult.   

Abstract

The aetiological diagnosis of pneumonia depends largely on culture-, antigen- or PCR-based tests. Atypical agents of pneumonia include Coxiella burnetii, Chlamydophila pneumoniae, Chlamydia psittaci, Legionella pneumophila, Francisella tularensis and Mycoplasma pneumoniae. In these cases, serological tests are commonly used for diagnosis. All of the above species were comparatively screened for by using the InoDiag multiplexed automatic immunofluorescence assay and established reference techniques. The InoDiag assay required 5 microL of serum, took 76 min per serum sample, and required an incubator, a fluorescence reader and interpretation software. In total, 248 single sera from patients were tested, for the diagnosis of pneumonia, and the results obtained with selected serum samples were compared with results obtained with the reference method. It was shown that, for the detection of Coxiella burnetii IgM, the automated assay had a sensitivity and specificity of 100%. For the detection of M. pneumoniae IgM, sensitivity was 100% and specificity was 98%. For the detection of Chlamydophila pneumoniae and Chlamydia psittaci IgG, sensitivity was 81% and specificity was 94%. For the detection of L. pneumoniae IgG, sensitivity was 63% and specificity was 98%. For the detection of F. tularensis IgG and IgM, sensitivity was 100% for both, and specificity was 95% and 100%, respectively. The performance of this serological assay was comparable to that of other assays reported in the literature. This preliminary study shows that the automatic InoDiag assay opens the way to immunofluorescence assay standardization.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19076843     DOI: 10.1111/j.1469-0691.2008.02119.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  8 in total

1.  Comparison of five commercial serological tests for the detection of anti-Chlamydia trachomatis antibodies.

Authors:  D Baud; L Regan; G Greub
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-28       Impact factor: 3.267

2.  Comparison of enzyme-linked immunosorbent assay with indirect immunofluorescence assay for the diagnosis of Mycoplasma pneumoniae infection.

Authors:  Chun-Hai Gao; Bao-Ju Ji; Chao Han; Mao-Shui Wang
Journal:  J Clin Lab Anal       Date:  2018-09-17       Impact factor: 2.352

3.  Tularemia: A Case Series of Patients Diagnosed at the National Reference Center for Rickettsioses From 2008 to 2017.

Authors:  Anne Darmon-Curti; François Darmon; Sophie Edouard; Aurélie Hennebique; Thomas Guimard; Guillaume Martin-Blondel; Timothée Klopfenstein; Jean-Philippe Talarmin; Didier Raoult; Max Maurin; Pierre-Edouard Fournier
Journal:  Open Forum Infect Dis       Date:  2020-09-19       Impact factor: 3.835

4.  Performance of a multiplexed serological microarray for the detection of antibodies against central nervous system pathogens.

Authors:  Anne J Jääskeläinen; Sari M Viitala; Satu Kurkela; Satu Hepojoki; Heidi Sillanpää; Hannimari Kallio-Kokko; Tomas Bergström; Jukka Suni; Ale Närvänen; Olli Vapalahti; Antti Vaheri
Journal:  J Microbiol Methods       Date:  2014-03-01       Impact factor: 2.363

5.  Proteomics paves the way for Q fever diagnostics.

Authors:  Malgorzata Kowalczewska; Zuzana Sekeyová; Didier Raoult
Journal:  Genome Med       Date:  2011-07-30       Impact factor: 11.117

6.  Serologic prevalence of amoeba-associated microorganisms in intensive care unit pneumonia patients.

Authors:  Sabri Bousbia; Laurent Papazian; Pierre Saux; Jean-Marie Forel; Jean-Pierre Auffray; Claude Martin; Didier Raoult; Bernard La Scola
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

7.  Recent and future developments in the epidemiology of the infectious diseases.

Authors:  Didier Raoult
Journal:  Eur J Epidemiol       Date:  2009-06-16       Impact factor: 8.082

8.  Evaluating the serological status of COVID-19 patients using an indirect immunofluorescent assay, France.

Authors:  S Edouard; P Colson; C Melenotte; F Di Pinto; L Thomas; B La Scola; M Million; H Tissot-Dupont; P Gautret; A Stein; P Brouqui; P Parola; J-C Lagier; D Raoult; Michel Drancourt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-11-11       Impact factor: 3.267

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.